Clinical Trial

Diesel Exhaust Induces Glucocorticoid Resistance

Study acronym: DIGR
Unknown Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated July 24, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The investigators are studying the effects of exposure to diesel exhaust on lung inflammation in the presence and absence of an inhaled corticosteroid. Although data is mixed, studies show that asthmatics have increased lung inflammation and worse symptoms during periods of higher air pollution despite taking their anti-inflammatory corticosteroid medication. One possible reason is that air pollution exposure may decrease the ability of corticosteroids to combat inflammation. To test this volunteers will inhale either a placebo or a corticosteroid, before sitting in an exposure booth for 2 hours breathing either filtered air or diluted diesel exhaust. Samples will be collected before and after exposure to analyze the effects of budesonide and diesel exhaust exposure.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT03615742
Lead Sponsor University of British Columbia
Collaborators: Canadian Institutes of Health Research (CIHR), AllerGen NCE Inc.
Conditions Exposure to Pollution, Glucocorticoid Resistance
Enrollment 30 participants
Start Date 2018-12-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-07-24